iNtRON Biotechnology, Inc. (KOSDAQ:048530)

iNtRON Biotechnology Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	32,719	34,359	40,987	25,811	75,170	59,926
Short-Term Investments	282.05	1,928	52.88	61,137	30,000	41.98
Trading Asset Securities	12,949	13,489	16,144	21,403	8,327	6,201
Cash & Short-Term Investments	45,949	49,776	57,184	108,351	113,497	66,169
Cash Growth	-19.82%	-12.95%	-47.22%	-4.53%	71.53%	-4.89%
Accounts Receivable	1,013	912.97	1,988	3,778	9,754	11,766
Other Receivables	252.42	111.12	660.26	471.4	851.74	286.45
Receivables	1,274	1,033	2,697	4,250	10,641	12,207
Inventory	1,036	1,124	1,011	800.39	1,002	1,532
Prepaid Expenses	-	-	-	36.69	69.19	328.74
Other Current Assets	116.94	292.81	87.89	490.14	303.53	1,090
Total Current Assets	48,377	52,226	60,980	113,928	125,513	81,327
Property, Plant & Equipment	19,613	19,740	22,696	15,031	13,758	11,951
Long-Term Investments	12,102	11,956	12,496	9,514	10,592	4,151
Other Intangible Assets	1,336	1,373	1,405	1,386	1,213	1,135
Long-Term Accounts Receivable	0	0	0	-	-	-
Long-Term Deferred Tax Assets	-	-	-	-	1,153	830.02
Other Long-Term Assets	1,198	1,079	1,038	1,070	1,136	1,142
Total Assets	82,625	86,375	98,615	140,959	153,365	100,536
Accounts Payable	60.05	60.63	0.42	97	561.02	206.67
Accrued Expenses	-	-	-	5.34	2.38	-
Short-Term Debt	861.44	-	-	30,810	29,494	9,854
Current Portion of Leases	162.95	168.48	144.62	174.98	132.88	259.68
Current Income Taxes Payable	-	-	-	-	1,267	352.73
Other Current Liabilities	4,310	1,109	640.94	1,130	1,796	2,030
Total Current Liabilities	5,394	1,338	785.97	32,218	33,254	12,704
Long-Term Debt	-	861.44	-	-	16,067	-
Long-Term Leases	181.97	214.72	258.3	286.37	61.62	174.27
Long-Term Deferred Tax Liabilities	101.63	74.99	83.99	1,565	-	-
Other Long-Term Liabilities	112.7	112.7	136.35	508.05	2,312	2,279
Total Liabilities	5,791	2,602	1,880	34,777	52,016	15,157
Common Stock	17,075	17,075	17,075	17,075	16,898	16,462
Additional Paid-In Capital	40,978	40,978	40,978	80,978	73,604	67,737
Retained Earnings	37,538	42,770	48,680	18,549	12,733	3,097
Treasury Stock	-19,871	-18,146	-10,960	-10,960	-1,967	-1,967
Comprehensive Income & Other	1,113	1,095	960.68	538.31	81.52	-62.54
Total Common Equity	76,834	83,773	96,734	106,181	101,349	85,266
Shareholders' Equity	76,834	83,773	96,734	106,181	101,349	85,379
Total Liabilities & Equity	82,625	86,375	98,615	140,959	153,365	100,536
Total Debt	1,206	1,245	402.91	31,271	45,756	10,288
Net Cash (Debt)	44,743	48,532	56,781	77,080	67,741	55,881
Net Cash Growth	-21.30%	-14.53%	-26.33%	13.79%	21.22%	2.53%
Net Cash Per Share	1342.01	1474.96	1710.73	2272.18	2008.38	1583.72
Filing Date Shares Outstanding	31.61	31.98	33.19	33.19	33.73	32.86
Total Common Shares Outstanding	31.61	31.98	33.19	33.19	33.73	32.86
Working Capital	42,982	50,888	60,194	81,710	92,259	68,623
Book Value Per Share	2430.39	2619.70	2914.42	3199.04	3004.79	2595.08
Tangible Book Value	75,498	82,400	95,329	104,796	100,137	84,131
Tangible Book Value Per Share	2388.12	2576.77	2872.08	3157.30	2968.84	2560.55
Land	3,659	3,659	4,072	2,631	2,631	2,513
Buildings	13,172	13,172	13,567	7,269	7,488	7,381
Machinery	4,759	4,757	1,826	2,382	1,235	982.02
Construction In Progress	1,119	1,119	-	-	-	-

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.